Results 61 to 70 of about 4,703,837 (246)

Clinical Approach to Assessment and Amelioration of Atherosclerotic Vascular Disease in Diabetes

Frontiers in Cardiovascular Medicine, 2020
Atherosclerotic cardiovascular disease is increased on average 2–3-fold in people with diabetes as compared to their non-diabetic counterparts and is the major cause of the increased morbidity and mortality in this disease. There is however heterogeneity
Ronald B. Goldberg
doaj   +1 more source

Novel Antidiabetic Agents: Cardiovascular and Safety Outcomes

Current Pharmaceutical Design, 2020
Background: Concerns of elevated cardiovascular risk with some anti-diabetic medications warranted trials on the cardiovascular outcome to demonstrate cardiovascular safety of newly marketed anti-diabetic drugs. Although these trials were initially designed to evaluate safety, some of these demonstrated significant cardiovascular benefits.
Gerasimos Siasos, Evanthia Bletsa, Panagiota K. Stampouloglou, Stavroula A. Paschou, Evangelos Oikonomou, Vasiliki Tsigkou, Alexios S. Antonopoulos, Manolis Vavuranakis, Dimitrios Tousoulis   +8 more
openaire   +3 more sources

Editor's Pick: Protecting The Heart in Cancer Patients: The Role of Cardio-Oncology

European Medical Journal Cardiology, 2017
Cardiac disease often impacts cancer therapy, from direct toxicity of cancer therapeutic agents to the coronary endothelium, the myocardium, heart valves, and other structures.
Ronald J. Krone
doaj  

How do breast cancer clinical trials approach cardiovascular safety: targeted or generalized?

Cardio-Oncology
Background Different breast cancer pharmacotherapy agents cause different forms of cardiovascular toxicity. We aim to assess if breast cancer pharmacotherapy trials approach cardiovascular safety in a targeted or generalized manner when administering ...
Arsalan Hamid, Gregg C. Fonarow, Javed Butler, Michael E. Hall   +3 more
doaj   +1 more source

Diabetes: the place of new therapies

Therapeutic Advances in Endocrinology and Metabolism, 2019
Until the discovery of insulin in 1921 there were no effective treatments for diabetes mellitus. After the advent of long-acting insulin, the first oral agents, sulfonylureas became available in the mid-1950s, quickly followed (outside of the United ...
Ketan Dhatariya
doaj   +1 more source

Albuminuria: An Underappreciated Risk Factor for Cardiovascular Disease

Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease
: Albuminuria, an established biomarker of the progression of chronic kidney disease, is also recognized as a biomarker for the risk of cardiovascular disease.
Joshua I Barzilay, Youssef M K Farag, Jeffrey Durthaler   +2 more
semanticscholar   +1 more source

Novel antiplatelet agents in the prevention of cardiovascular complications – focus on ticagrelor

Vascular Health and Risk Management, 2010
Margaret M Marczewski1, Marek Postula1,2, Dariusz Kosior111st Chair and Department of Cardiology, Central University Hospital, Medical University of Warsaw, Warsaw, Poland; 2Department of Experimental and Clinical Pharmacology, Medical University of ...
Margaret M Marczewski, Marek Postula, Dariusz Kosior   +2 more
doaj  

Seaweeds as Preventive Agents for Cardiovascular Diseases: From Nutrients to Functional Foods

Marine Drugs, 2015
Being naturally enriched in key nutrients and in various health-promoting compounds, seaweeds represent promising candidates for the design of functional foods.
S. Cardoso, Olívia R. Pereira, A. Seca, D. Pinto, Artur M. S. Silva   +4 more
semanticscholar   +1 more source

Cardiovascular and hematologic effects produced by chronic treatment with etoricoxib in normotensive rats Efeitos cardiovasculares e hematológicos produzidos pelo tratamento crônico com etoricoxib em ratos normotensos

Acta Cirúrgica Brasileira, 2009
PURPOSE: Evaluate the cardiovascular and hematological effects produced by chronic treatment with two dosis of etoricoxib in Wistar normotensive rats. METHODS: Thirty rats have been used and divided into one control group and two etoricoxib (10mg/kg and ...
Nilo César do Vale Baracho, Guilherme Pedrosa Guizelli, Beatriz Leone Carmello, Danielle de Souza Sanches, Felipe Moraes Costa Silva, José Marcos dos Reis, Jarbas de Brito   +6 more
doaj   +1 more source

Association of clinical characteristics, antidiabetic and cardiovascular agents with diabetes mellitus and COVID-19: a 7-month follow-up cohort study. [PDF]

J Diabetes Metab Disord, 2021
Pazoki M, Chichagi F, Hadadi A, Kafan S, Montazeri M, Kazemian S, Aminorroaya A, Ebrahimi M, Ashraf H, Hazaveh MM, Khajavi MR, Moharari RS, Sharifnia SH, Saleh SK, Rahimzadeh H, Goodarzi N, Heydarian P.   +16 more
europepmc   +1 more source